This brand name is authorized in Estonia
The drug DOUBLEPEN OA contains a combination of these active pharmaceutical ingredients (APIs):
|
1
UNII 3HXR312Z9M - OBIDOXIME CHLORIDE
|
|
|
|
2
Atropine
UNII 7C0697DR9I - ATROPINE
|
|
Atropine is an antimuscarinic agent which competitively antagonises acetylcholine at postganglionic nerve endings, thus affecting receptors if the exocrine glands, smooth muscle, cardiac muscle and the central nervous system. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| V03AB | Antidotes | V Various → V03 All other therapeutic products → V03A All other therapeutic products |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1835513 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
